Skip to main content
Equibles

BLAIR WILLIAM & CO/IL

Position in NTLA — Intellia Therapeutics, Inc.

CIK 902367 CHICAGO, IL
Back to NTLA Full portfolio

Position in NTLA

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$2,582,195
+$2,348,743 QoQ
Shares Held
152,612
+738.1% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#79
of 330 holders
Holding Since
Dec 2020
18 quarters on record
Voting authority Sole 78% Shared 0% None 22%

Common Shares in NTLA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BLAIR WILLIAM & CO/IL holds $184,064,705 across 61 Biotechnology names. NTLA ranks #12 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TECH
BIO-TECHNE Corp
 513,573 $36,283,932
2 TWST
Twist Bioscience Corp
 256,556 $26,394,481
3 ARGX
Argenx SE
 27,666 $25,667,684
4 VKTX
Viking Therapeutics, Inc.
 416,766 $16,258,041
5 EXEL
Exelixis, Inc.
 243,215 $13,233,328
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 18,400 $9,139,832
7 SLDB
Solid Biosciences Inc.
 756,277 $7,555,207
8 AXSM
Axsome Therapeutics, Inc.
 23,450 $5,739,856

All Filings in NTLA

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,582,195 152,612
2026-03-31 $233,452 18,210
2025-12-31 $163,258 18,160
2025-09-30 $348,163 20,160
2024-03-31 $283,545 10,307
2023-12-31 $312,522 10,250
2023-09-30 $292,485 9,250
2023-06-30 $377,215 9,250
2023-03-31 $270,207 7,250
2022-12-31 $256,790 7,360
2022-09-30 $589,706 10,538
2022-06-30 $536,233 10,360
2022-03-31 $753,006 10,362
2021-12-31 $1,095,138 9,262
2021-09-30 $1,222,106 9,110
2021-06-30 $1,475,000 9,110
2021-03-31 $731,123 9,110
2020-12-31 $441,184 8,110